MENU
IBRX
AS OF
Dec 12 closing price
Price
$2.36
Change
+$0.17 (+7.76%)
Capitalization
2.32B
80 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
IBRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ImmunityBio (IBRX) Ownership - Who owns ImmunityBio?

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
3530 John Hopkins Court
Phone
+1 844 696-5235
Employees
628
Web
https://www.immunitybio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.32B
P/E Ratio
N/A
Total Cash
257.81M
Projected Growth
N/A
Total Debt
542.25M
Revenue
82.56M
Risk (Beta)
0.13
Dividend Yield
N/A
Total Cash/Share
0.26
Total Debt/Equity
N/A
Revenue/Share
0.10 USD as % of share price

Fundamentals

IBRX
Capitalization
2.33B
P/E Ratio
N/A
Risk (Beta)
0.13
Dividend Yield
N/A
Total Cash
258M
Total Cash/Share
0.26
Total Debt
542M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.10%
Revenue
82.6M
ROE
N/A
Book Value
-524.32M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.39
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
98K
Current Ratio
5.77
Current Revenue Per Employee
47638.93
Dividends Per Share - Security
N/A
EBITDA
-232.66M
Float
N/A
Float - Current
N/A
Gross Income Margin
99.45
Revenue To Assets
-78.91
Shares Held By Institutions
516M
Shares Outstanding - Current
985M
Total Liabilities
1.04B
Total Volume MTD
N/A
Value
1
Gain YTD
-14.453
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IBRX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IBRX showed earnings on November 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading for IBRX
A.I. Advisor
published General Information

General Information

a producer of cancer treatment products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3530 John Hopkins Court
Phone
+1 844 696-5235
Employees
628
Web
https://www.immunitybio.com